BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 11255193)

  • 1. Evaluation of carboxymethylcellulose, hydroxypropylmethylcellulose, and aluminum hydroxide as potential carriers for rhBMP-2.
    Santa-Comba A; Pereira A; Lemos R; Santos D; Amarante J; Pinto M; Tavares P; Bahia F
    J Biomed Mater Res; 2001 Jun; 55(3):396-400. PubMed ID: 11255193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The evaluation of lyophilized polymer matrices for administering recombinant human bone morphogenetic protein-2.
    Duggirala SS; Rodgers JB; DeLuca PP
    Pharm Dev Technol; 1996 Jul; 1(2):165-74. PubMed ID: 9552343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibroblast growth factor-2 augments recombinant human bone morphogenetic protein-2-induced osteoinductive activity.
    Tanaka E; Ishino Y; Sasaki A; Hasegawa T; Watanabe M; Dalla-Bona DA; Yamano E; van Eijden TM; Tanne K
    Ann Biomed Eng; 2006 May; 34(5):717-25. PubMed ID: 16568346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthetic thermoreversible polymers are compatible with osteoinductive activity of recombinant human bone morphogenetic protein 2.
    Gao TJ; Kousinioris NA; Wozney JM; Winn S; Uludag H
    Tissue Eng; 2002 Jul; 8(3):429-40. PubMed ID: 12167229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ridge augmentation following implantation of recombinant human bone morphogenetic protein-2 in the dog.
    Barboza EP; Duarte ME; Geolás L; Sorensen RG; Riedel GE; Wikesjö UM
    J Periodontol; 2000 Mar; 71(3):488-96. PubMed ID: 10776939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of ceramics composed of different hydroxyapatite to tricalcium phosphate ratios as carriers for rhBMP-2.
    Alam MI; Asahina I; Ohmamiuda K; Takahashi K; Yokota S; Enomoto S
    Biomaterials; 2001 Jun; 22(12):1643-51. PubMed ID: 11374466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carrier dependent cell differentiation of bone morphogenetic protein-2 induced osteogenesis and chondrogenesis during the early implantation stage in rats.
    Takita H; Vehof JW; Jansen JA; Yamamoto M; Tabata Y; Tamura M; Kuboki Y
    J Biomed Mater Res A; 2004 Oct; 71(1):181-9. PubMed ID: 15368268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term stability of bone tissues induced by an osteoinductive biomaterial, recombinant human bone morphogenetic protein-2 and a biodegradable carrier.
    Kokubo S; Mochizuki M; Fukushima S; Ito T; Nozaki K; Iwai T; Takahashi K; Yokota S; Miyata K; Sasaki N
    Biomaterials; 2004 May; 25(10):1795-803. PubMed ID: 14738843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of rhBMP-2 pharmacokinetics implanted with biomaterial carriers in the rat ectopic model.
    Uludag H; D'Augusta D; Palmer R; Timony G; Wozney J
    J Biomed Mater Res; 1999 Aug; 46(2):193-202. PubMed ID: 10379997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of a freeze-dried CMC/PLGA microsphere matrix of rhBMP-2 on bone healing.
    Schrier JA; Fink BF; Rodgers JB; Vasconez HC; DeLuca PP
    AAPS PharmSciTech; 2001 Oct; 2(3):E18. PubMed ID: 14727877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Posterior lumbar interbody fusion using recombinant human bone morphogenetic protein type 2 with cylindrical interbody cages.
    Haid RW; Branch CL; Alexander JT; Burkus JK
    Spine J; 2004; 4(5):527-38; discussion 538-9. PubMed ID: 15363423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initial fusion rates with recombinant human bone morphogenetic protein-2/compression resistant matrix and a hydroxyapatite and tricalcium phosphate/collagen carrier in posterolateral spinal fusion.
    Glassman SD; Dimar JR; Carreon LY; Campbell MJ; Puno RM; Johnson JR
    Spine (Phila Pa 1976); 2005 Aug; 30(15):1694-8. PubMed ID: 16094268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Posterolateral lumbar intertransverse process spine arthrodesis with recombinant human bone morphogenetic protein 2/hydroxyapatite-tricalcium phosphate after laminectomy in the nonhuman primate.
    Boden SD; Martin GJ; Morone MA; Ugbo JL; Moskovitz PA
    Spine (Phila Pa 1976); 1999 Jun; 24(12):1179-85. PubMed ID: 10382242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of surgical implantation of recombinant human bone morphogenetic protein-2 in a bioabsorbable collagen sponge or calcium phosphate putty carrier in intrabony periodontal defects in the baboon.
    Blumenthal NM; Koh-Kunst G; Alves ME; Miranda D; Sorensen RG; Wozney JM; Wikesjö UM
    J Periodontol; 2002 Dec; 73(12):1494-506. PubMed ID: 12546100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of recombinant human bone morphogenetic protein 2 (rhBMP-2) to promote spinal fusion in a nonhuman primate anterior interbody fusion model.
    Hecht BP; Fischgrund JS; Herkowitz HN; Penman L; Toth JM; Shirkhoda A
    Spine (Phila Pa 1976); 1999 Apr; 24(7):629-36. PubMed ID: 10209790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delivery systems for BMPs: factors contributing to protein retention at an application site.
    Uludag H; Gao T; Porter TJ; Friess W; Wozney JM
    J Bone Joint Surg Am; 2001; 83-A Suppl 1(Pt 2):S128-35. PubMed ID: 11314790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of recombinant human bone morphogenetic protein-2 on the repair of alveolar ridge defects in baboons.
    Miranda DA; Blumenthal NM; Sorensen RG; Wozney JM; Wikesjö UM
    J Periodontol; 2005 Feb; 76(2):210-20. PubMed ID: 15974844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential of porous poly-D,L-lactide-co-glycolide particles as a carrier for recombinant human bone morphogenetic protein-2 during osteoinduction in vivo.
    Boyan BD; Lohmann CH; Somers A; Niederauer GG; Wozney JM; Dean DD; Carnes DL; Schwartz Z
    J Biomed Mater Res; 1999 Jul; 46(1):51-9. PubMed ID: 10357135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primate mandibular reconstruction with prefabricated, vascularized tissue-engineered bone flaps and recombinant human bone morphogenetic protein-2 implanted in situ.
    Zhou M; Peng X; Mao C; Xu F; Hu M; Yu GY
    Biomaterials; 2010 Jun; 31(18):4935-43. PubMed ID: 20346504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of rhBMP-2 around endosseous implants with and without membranes in the canine model.
    Jones AA; Buser D; Schenk R; Wozney J; Cochran DL
    J Periodontol; 2006 Jul; 77(7):1184-93. PubMed ID: 16805681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.